BIOMOLEX AS

0779 OSLO

Finances

Share Ownership

Return on Equity

297,25 %

Current Ratio

0,28

Debt-to-Equity Ratio

−3,25

Key figures (NOK)	2022	2021	2020	2019
Revenue	1 332 000	2 264 000	2 757 000	4 434 000
Net Income	−1 947 000	−1 822 000	−2 654 000	−302 000
Total Assets	1 897 000	4 277 000	6 808 000	10 506 000
Total Equity	−655 000	1 292 000	3 115 000	5 768 000

Income (NOK)	2022	2021	2020	2019
Revenue	1 332 000	2 264 000	2 757 000	4 434 000
Expenditure	3 275 000	4 085 000	5 393 000	4 730 000
Operating Profit	−1 943 000	−1 820 000	−2 635 000	−297 000
Financial Income	0	1 000	13 000	6 000
Financial Costs	5 000	3 000	31 000	12 000
Financial Balance	−5 000	−2 000	−18 000	−6 000
Earnings Before Tax	−1 947 000	−1 822 000	−2 654 000	−302 000
Tax	0	0	0	0
Net Income	−1 947 000	−1 822 000	−2 654 000	−302 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	1 779 000	3 741 000	5 995 000	8 557 000
Total Current Assets	118 000	536 000	813 000	1 949 000
Total Assets	1 897 000	4 277 000	6 808 000	10 506 000
Total Retained Equity	−1 487 000	460 000	2 283 000	4 936 000
Total Equity	−655 000	1 292 000	3 115 000	5 768 000
Total Long-Term Debt	2 129 000	715 000	1 163 000	1 681 000
Total Current Debt	423 000	2 270 000	2 530 000	3 057 000
Total Equity and Debt	1 897 000	4 277 000	6 808 000	10 506 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	1 100 000	1 485 000	2 136 000	856 000
Other Income	232 000	779 000	621 000	3 578 000
Revenue	1 332 000	2 264 000	2 757 000	4 434 000
Cost of Goods Sold	0	0	0	66 000
Salary Costs	566 000	628 000	806 000	143 000
Depreciation	1 963 000	3 080 000	3 975 000	3 692 000
Impairment	0	0	0	0
Expenditure	3 275 000	4 085 000	5 393 000	4 730 000
Operating Profit	−1 943 000	−1 820 000	−2 635 000	−297 000
Financial Income	0	1 000	13 000	6 000
Financial Costs	5 000	3 000	31 000	12 000
Financial Balance	−5 000	−2 000	−18 000	−6 000
Dividends	0	0	0	0
Net Income	−1 947 000	−1 822 000	−2 654 000	−302 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	1 779 000	3 741 000	5 995 000	8 557 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	0	0	0	0
Total Tangible Assets	0	0	0	0
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	1 779 000	3 741 000	5 995 000	8 557 000
Stock	0	0	0	0
Total Investments	0	0	0	0
Cash, Bank	101 000	200 000	330 000	163 000
Total Current Assets	118 000	536 000	813 000	1 949 000
Total Assets	1 897 000	4 277 000	6 808 000	10 506 000
Total Equity	−655 000	1 292 000	3 115 000	5 768 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	2 129 000	715 000	1 163 000	1 681 000
Creditors	34 000	8 000	102 000	13 000
Unpaid Taxes	300 000	346 000	413 000	399 000
Dividends	0	0	0	0
Other Current Debt	89 000	1 916 000	2 015 000	2 645 000
Total Current Debt	423 000	2 270 000	2 530 000	3 057 000
Total Equity and Debt	1 897 000	4 277 000	6 808 000	10 506 000

Financial indicators	2022	2021	2020	2019
Return on Equity	297,25 %	−141,02 %	−85,2 %	−5,24 %
Debt-to-Equity Ratio	−3,25	0,55	0,37	0,29
Operating Profit Margin	−145,87 %	−80,39 %	−95,57 %	−6,7 %
Current Ratio	0,28	0,24	0,32	0,64
Quick Ratio	0,28	0,24	0,32	0,64
Equity Ratio	−0,35	0,3	0,46	0,55
Gross Profit Margin	100 %	100 %	100 %	98,51 %